HPV
- autism
- Cancer
- CBCD
- CMV
- fda
- Genital herpes
- Genital wart
- HPV
- Latent virus
- Other
- toxic vaccine
- VikiVirus
HPV Survey Shows a Confused Public; CBCD Helps End Confusion on HPV Issues
The Center for the Biology of Chronic Disease (CBCD) presents the results of its monthly “HPV IQ survey,” which measures the public’s current knowledge of HPV
New Study Shows Why Herpes Reactivates
The immune system may have greater trouble controlling the herpes group cytomegalovirus (CMV) and preventing breakouts when it has to combat other viral or bacterial infections. More
Herpes Zoster Patients Not at Increased Risk for Cancer
When compared with the frequency of occurrence in the general population, herpes zoster patients were not at increased risk for cancer. More
Herpes Vaccine in Clinical Trials; Gene-Eden-VIR Remains Effective, Antiviral Natural Remedy
Designed to stimulate T cell and B cell immune responses, GEN-003 is an investigational vaccine that works to potentially reduce the frequency and severity of Herpes Simplex Virus type 2 (HSV-2) infection. More
How Long Does the Herpes Virus Remain Latent? CBCD Receives Questions on Herpes Virus
The CBCD has learned through a recent survey that there is an alarming lack of knowledge regarding Herpes infection and prevention.
How soon is it safe to have sex after having genital warts?
Many people are in the dark about how soon it is safe for them to have sex after a bout with genital warts.
